Monogram Orthopaedics, Inc. (NASDAQ: MGRM) Stock Competitors & Peer Comparison
See MGRM's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MGRM and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MGRM | $6.00 | -1.80% | 243.8M | -12.00 | -$0.50 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $101.29 | +0.22% | 175.3B | 19.44 | $5.21 | +2.45% |
| MDT | $88.64 | +0.15% | 113.5B | 16.03 | $5.53 | +3.24% |
| SYK | $272.36 | +0.97% | 104.5B | 20.35 | $13.39 | +1.28% |
| BSX | $43.92 | -1.70% | 65.3B | 14.17 | $3.10 | N/A |
| EW | $86.29 | +0.65% | 49.7B | 31.96 | $2.70 | N/A |
| DXCM | $86.62 | -0.97% | 32.7B | 33.97 | $2.55 | N/A |
| GEHC | $66.63 | +0.38% | 30.1B | 14.61 | $4.56 | +0.21% |
| PHG | $24.96 | +1.67% | 24.4B | 14.26 | $1.75 | +3.97% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
MGRM vs BSX-PA Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, MGRM's ROE is -0.85%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, MGRM is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
MGRM vs ABT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ABT trades at $101.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ABT's P/E ratio is 19.44. In terms of profitability, MGRM's ROE is -0.85%, compared to ABT's ROE of +0.11%. Regarding short-term risk, MGRM is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ABT's competition here
Medtronic plc (NYSE: MDT)
MGRM vs MDT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, MDT has a market cap of 113.5B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while MDT trades at $88.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas MDT's P/E ratio is 16.03. In terms of profitability, MGRM's ROE is -0.85%, compared to MDT's ROE of +0.11%. Regarding short-term risk, MGRM is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
MGRM vs SYK Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SYK has a market cap of 104.5B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SYK trades at $272.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SYK's P/E ratio is 20.35. In terms of profitability, MGRM's ROE is -0.85%, compared to SYK's ROE of +0.16%. Regarding short-term risk, MGRM is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
MGRM vs BSX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BSX has a market cap of 65.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BSX trades at $43.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BSX's P/E ratio is 14.17. In terms of profitability, MGRM's ROE is -0.85%, compared to BSX's ROE of +0.15%. Regarding short-term risk, MGRM is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
MGRM vs EW Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, EW has a market cap of 49.7B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while EW trades at $86.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas EW's P/E ratio is 31.96. In terms of profitability, MGRM's ROE is -0.85%, compared to EW's ROE of +0.10%. Regarding short-term risk, MGRM is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
MGRM vs DXCM Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while DXCM trades at $86.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas DXCM's P/E ratio is 33.97. In terms of profitability, MGRM's ROE is -0.85%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, MGRM is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
MGRM vs GEHC Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, GEHC has a market cap of 30.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while GEHC trades at $66.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas GEHC's P/E ratio is 14.61. In terms of profitability, MGRM's ROE is -0.85%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, MGRM is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
MGRM vs PHG Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, PHG has a market cap of 24.4B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while PHG trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas PHG's P/E ratio is 14.26. In terms of profitability, MGRM's ROE is -0.85%, compared to PHG's ROE of +0.10%. Regarding short-term risk, MGRM is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
MGRM vs ZBH Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ZBH trades at $91.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ZBH's P/E ratio is 10.73. In terms of profitability, MGRM's ROE is -0.85%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, MGRM is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
MGRM vs ABMD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, MGRM's ROE is -0.85%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, MGRM is less volatile compared to ABMD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
MGRM vs SWAV Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, MGRM's ROE is -0.85%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, MGRM is less volatile compared to SWAV. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
MGRM vs PEN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while PEN trades at $318.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas PEN's P/E ratio is 83.25. In terms of profitability, MGRM's ROE is -0.85%, compared to PEN's ROE of +0.11%. Regarding short-term risk, MGRM is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
MGRM vs SNN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SNN trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SNN's P/E ratio is 18.17. In terms of profitability, MGRM's ROE is -0.85%, compared to SNN's ROE of +0.12%. Regarding short-term risk, MGRM is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
MGRM vs BIO-B Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, MGRM's ROE is -0.85%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, MGRM is similarly volatile compared to BIO-B. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
MGRM vs ALGN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ALGN has a market cap of 10.5B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ALGN trades at $146.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ALGN's P/E ratio is 13.38. In terms of profitability, MGRM's ROE is -0.85%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, MGRM is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
MGRM vs BIO Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BIO has a market cap of 10.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BIO trades at $381.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BIO's P/E ratio is 41.05. In terms of profitability, MGRM's ROE is -0.85%, compared to BIO's ROE of +0.03%. Regarding short-term risk, MGRM is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
MGRM vs GMED Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while GMED trades at $74.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas GMED's P/E ratio is 16.79. In terms of profitability, MGRM's ROE is -0.85%, compared to GMED's ROE of +0.12%. Regarding short-term risk, MGRM is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
MGRM vs BRKR Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BRKR trades at $64.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BRKR's P/E ratio is 32.25. In terms of profitability, MGRM's ROE is -0.85%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, MGRM is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
MGRM vs BRKRP Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BRKRP has a market cap of 9.4B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BRKRP trades at $470.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BRKRP's P/E ratio is 255.66. In terms of profitability, MGRM's ROE is -0.85%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, MGRM is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BRKRP's competition here
Insulet Corp. (NASDAQ: PODD)
MGRM vs PODD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, PODD has a market cap of 9.4B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while PODD trades at $136.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas PODD's P/E ratio is 23.19. In terms of profitability, MGRM's ROE is -0.85%, compared to PODD's ROE of +0.27%. Regarding short-term risk, MGRM is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
MGRM vs MASI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas MASI's P/E ratio is 44.43. In terms of profitability, MGRM's ROE is -0.85%, compared to MASI's ROE of +0.09%. Regarding short-term risk, MGRM is similarly volatile compared to MASI. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
MGRM vs GKOS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while GKOS trades at $154.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas GKOS's P/E ratio is -180.02. In terms of profitability, MGRM's ROE is -0.85%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, MGRM is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check GKOS's competition here
Haemonetics Corporation (NYSE: HAE)
MGRM vs HAE Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while HAE trades at $105.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas HAE's P/E ratio is 21.02. In terms of profitability, MGRM's ROE is -0.85%, compared to HAE's ROE of +0.11%. Regarding short-term risk, MGRM is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
MGRM vs NARI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, MGRM's ROE is -0.85%, compared to NARI's ROE of -0.00%. Regarding short-term risk, MGRM is less volatile compared to NARI. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
MGRM vs ITGR Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ITGR's P/E ratio is 19.89. In terms of profitability, MGRM's ROE is -0.85%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, MGRM is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
MGRM vs LIVN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while LIVN trades at $76.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas LIVN's P/E ratio is 18.20. In terms of profitability, MGRM's ROE is -0.85%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, MGRM is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
MGRM vs AXNX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas AXNX's P/E ratio is -709.80. In terms of profitability, MGRM's ROE is -0.85%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, MGRM is similarly volatile compared to AXNX. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
MGRM vs IRTC Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while IRTC trades at $110.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas IRTC's P/E ratio is -256.70. In terms of profitability, MGRM's ROE is -0.85%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, MGRM is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
MGRM vs NEOG Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while NEOG trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas NEOG's P/E ratio is 49.14. In terms of profitability, MGRM's ROE is -0.85%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, MGRM is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
MGRM vs TMDX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while TMDX trades at $85.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas TMDX's P/E ratio is 43.29. In terms of profitability, MGRM's ROE is -0.85%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, MGRM is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check TMDX's competition here
Butterfly Network, Inc. (NYSE: BFLY)
MGRM vs BFLY Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BFLY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BFLY's P/E ratio is -39.13. In terms of profitability, MGRM's ROE is -0.85%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, MGRM is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
MGRM vs AXGN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while AXGN trades at $43.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas AXGN's P/E ratio is 114.18. In terms of profitability, MGRM's ROE is -0.85%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, MGRM is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
MGRM vs UFPT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while UFPT trades at $295.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas UFPT's P/E ratio is 30.20. In terms of profitability, MGRM's ROE is -0.85%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, MGRM is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
MGRM vs NUVA Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, MGRM's ROE is -0.85%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, MGRM is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
MGRM vs INSP Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while INSP trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas INSP's P/E ratio is 31.06. In terms of profitability, MGRM's ROE is -0.85%, compared to INSP's ROE of +0.18%. Regarding short-term risk, MGRM is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
MGRM vs ESTA Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ESTA trades at $65.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ESTA's P/E ratio is -52.36. In terms of profitability, MGRM's ROE is -0.85%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, MGRM is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
MGRM vs NVCR Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while NVCR trades at $15.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas NVCR's P/E ratio is -12.18. In terms of profitability, MGRM's ROE is -0.85%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, MGRM is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
MGRM vs ATEC Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ATEC trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ATEC's P/E ratio is -168.67. In terms of profitability, MGRM's ROE is -0.85%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, MGRM is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
MGRM vs CNMD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CNMD trades at $45.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CNMD's P/E ratio is 9.97. In terms of profitability, MGRM's ROE is -0.85%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, MGRM is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
MGRM vs HSKA Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, MGRM's ROE is -0.85%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, MGRM is similarly volatile compared to HSKA. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
MGRM vs IART Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while IART trades at $16.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas IART's P/E ratio is 6.83. In terms of profitability, MGRM's ROE is -0.85%, compared to IART's ROE of -0.01%. Regarding short-term risk, MGRM is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
MGRM vs AVNS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas AVNS's P/E ratio is 27.77. In terms of profitability, MGRM's ROE is -0.85%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, MGRM is less volatile compared to AVNS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
MGRM vs SILK Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, MGRM's ROE is -0.85%, compared to SILK's ROE of -0.35%. Regarding short-term risk, MGRM is less volatile compared to SILK. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
MGRM vs AORT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while AORT trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas AORT's P/E ratio is 37.75. In terms of profitability, MGRM's ROE is -0.85%, compared to AORT's ROE of -0.01%. Regarding short-term risk, MGRM is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check AORT's competition here
Paragon 28, Inc. (NYSE: FNA)
MGRM vs FNA Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, MGRM's ROE is -0.85%, compared to FNA's ROE of -0.35%. Regarding short-term risk, MGRM is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
MGRM vs IRMD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while IRMD trades at $85.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas IRMD's P/E ratio is 43.10. In terms of profitability, MGRM's ROE is -0.85%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, MGRM is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
MGRM vs TNDM Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while TNDM trades at $15.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas TNDM's P/E ratio is -16.90. In terms of profitability, MGRM's ROE is -0.85%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, MGRM is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
MGRM vs ENOV Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ENOV trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ENOV's P/E ratio is 5.29. In terms of profitability, MGRM's ROE is -0.85%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, MGRM is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
MGRM vs LMRI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, LMRI has a market cap of 981M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while LMRI trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas LMRI's P/E ratio is -19.86. In terms of profitability, MGRM's ROE is -0.85%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, MGRM is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
MGRM vs PRCT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, PRCT has a market cap of 979M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while PRCT trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas PRCT's P/E ratio is -8.87. In terms of profitability, MGRM's ROE is -0.85%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, MGRM is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
MGRM vs BBNX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BBNX has a market cap of 967.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BBNX trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BBNX's P/E ratio is -13.04. In terms of profitability, MGRM's ROE is -0.85%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, MGRM is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BBNX's competition here
Bioventus Inc. (NASDAQ: BVS)
MGRM vs BVS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BVS has a market cap of 935.6M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BVS trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BVS's P/E ratio is 18.17. In terms of profitability, MGRM's ROE is -0.85%, compared to BVS's ROE of +0.28%. Regarding short-term risk, MGRM is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
MGRM vs CBLL Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CBLL has a market cap of 898.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CBLL trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CBLL's P/E ratio is -13.46. In terms of profitability, MGRM's ROE is -0.85%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, MGRM is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
MGRM vs CSII Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, MGRM's ROE is -0.85%, compared to CSII's ROE of -0.14%. Regarding short-term risk, MGRM is less volatile compared to CSII. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
MGRM vs SIBN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SIBN has a market cap of 824.5M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SIBN trades at $18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SIBN's P/E ratio is -54.68. In terms of profitability, MGRM's ROE is -0.85%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, MGRM is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
MGRM vs INMD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, INMD has a market cap of 819.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while INMD trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas INMD's P/E ratio is 9.90. In terms of profitability, MGRM's ROE is -0.85%, compared to INMD's ROE of +0.12%. Regarding short-term risk, MGRM is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
MGRM vs VREX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas VREX's P/E ratio is 19.42. In terms of profitability, MGRM's ROE is -0.85%, compared to VREX's ROE of +0.05%. Regarding short-term risk, MGRM is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
MGRM vs AHCO Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, AHCO has a market cap of 767.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while AHCO trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas AHCO's P/E ratio is 11.51. In terms of profitability, MGRM's ROE is -0.85%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, MGRM is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
MGRM vs AVR Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, AVR has a market cap of 747.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while AVR trades at $7.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas AVR's P/E ratio is -3.96. In terms of profitability, MGRM's ROE is -0.85%, compared to AVR's ROE of -0.78%. Regarding short-term risk, MGRM is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
MGRM vs CTKB Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CTKB has a market cap of 729.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CTKB trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CTKB's P/E ratio is -29.93. In terms of profitability, MGRM's ROE is -0.85%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, MGRM is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
MGRM vs SRDX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SRDX's P/E ratio is -34.66. In terms of profitability, MGRM's ROE is -0.85%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, MGRM is similarly volatile compared to SRDX. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check SRDX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
MGRM vs SSII Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SSII has a market cap of 590.4M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SSII trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SSII's P/E ratio is -49.17. In terms of profitability, MGRM's ROE is -0.85%, compared to SSII's ROE of -0.27%. Regarding short-term risk, MGRM is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SSII's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
MGRM vs APEN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, MGRM's ROE is -0.85%, compared to APEN's ROE of -0.85%. Regarding short-term risk, MGRM is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
MGRM vs KIDS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, KIDS has a market cap of 579.2M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while KIDS trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas KIDS's P/E ratio is -19.11. In terms of profitability, MGRM's ROE is -0.85%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, MGRM is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
MGRM vs DCTH Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, DCTH has a market cap of 538.5M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while DCTH trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas DCTH's P/E ratio is 1560.00. In terms of profitability, MGRM's ROE is -0.85%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, MGRM is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
MGRM vs ZIMV Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, MGRM's ROE is -0.85%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, MGRM is similarly volatile compared to ZIMV. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
MGRM vs CERS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CERS has a market cap of 528M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CERS trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CERS's P/E ratio is -87.04. In terms of profitability, MGRM's ROE is -0.85%, compared to CERS's ROE of -0.10%. Regarding short-term risk, MGRM is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
MGRM vs TCMD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, TCMD has a market cap of 512.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while TCMD trades at $22.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas TCMD's P/E ratio is 21.05. In terms of profitability, MGRM's ROE is -0.85%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, MGRM is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check TCMD's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
MGRM vs PACB Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, PACB has a market cap of 503.2M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while PACB trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas PACB's P/E ratio is -3.95. In terms of profitability, MGRM's ROE is -0.85%, compared to PACB's ROE of -49.62%. Regarding short-term risk, MGRM is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check PACB's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
MGRM vs SGHT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SGHT has a market cap of 485.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SGHT trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SGHT's P/E ratio is -15.95. In terms of profitability, MGRM's ROE is -0.85%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, MGRM is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SGHT's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
MGRM vs NPCE Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, NPCE has a market cap of 479.4M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while NPCE trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas NPCE's P/E ratio is -24.67. In terms of profitability, MGRM's ROE is -0.85%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, MGRM is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
MGRM vs CLPT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CLPT has a market cap of 444.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CLPT trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CLPT's P/E ratio is -12.57. In terms of profitability, MGRM's ROE is -0.85%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, MGRM is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
MGRM vs SENS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SENS has a market cap of 417.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SENS trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SENS's P/E ratio is -4.48. In terms of profitability, MGRM's ROE is -0.85%, compared to SENS's ROE of -1.66%. Regarding short-term risk, MGRM is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
MGRM vs OFIX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, OFIX has a market cap of 381.6M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while OFIX trades at $9.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas OFIX's P/E ratio is -6.15. In terms of profitability, MGRM's ROE is -0.85%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, MGRM is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
MGRM vs CV Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CV has a market cap of 332.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CV trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CV's P/E ratio is -10.56. In terms of profitability, MGRM's ROE is -0.85%, compared to CV's ROE of -1.78%. Regarding short-term risk, MGRM is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
MGRM vs SMLR Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas SMLR's P/E ratio is 3.92. In terms of profitability, MGRM's ROE is -0.85%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, MGRM is similarly volatile compared to SMLR. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check SMLR's competition here
Avita Medical Inc. (NASDAQ: RCEL)
MGRM vs RCEL Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, RCEL has a market cap of 294.1M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while RCEL trades at $11.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas RCEL's P/E ratio is -8.22. In terms of profitability, MGRM's ROE is -0.85%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, MGRM is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check RCEL's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
MGRM vs TMCI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, TMCI has a market cap of 291.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while TMCI trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas TMCI's P/E ratio is -4.79. In terms of profitability, MGRM's ROE is -0.85%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, MGRM is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
MGRM vs CATX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, CATX has a market cap of 286.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while CATX trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas CATX's P/E ratio is -1.89. In terms of profitability, MGRM's ROE is -0.85%, compared to CATX's ROE of -0.42%. Regarding short-term risk, MGRM is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
MGRM vs TLSI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, TLSI has a market cap of 267.2M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while TLSI trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas TLSI's P/E ratio is -2.58. In terms of profitability, MGRM's ROE is -0.85%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, MGRM is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check TLSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MGRM vs INFU Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, INFU has a market cap of 257.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while INFU trades at $12.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas INFU's P/E ratio is 31.10. In terms of profitability, MGRM's ROE is -0.85%, compared to INFU's ROE of +0.15%. Regarding short-term risk, MGRM is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check INFU's competition here
Electromed, Inc. (AMEX: ELMD)
MGRM vs ELMD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ELMD has a market cap of 231.4M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ELMD trades at $27.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ELMD's P/E ratio is 21.34. In terms of profitability, MGRM's ROE is -0.85%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, MGRM is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
MGRM vs NVRO Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, MGRM's ROE is -0.85%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, MGRM is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
MGRM vs PROF Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, PROF has a market cap of 209.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while PROF trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas PROF's P/E ratio is -5.88. In terms of profitability, MGRM's ROE is -0.85%, compared to PROF's ROE of -0.56%. Regarding short-term risk, MGRM is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
MGRM vs RXST Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, RXST has a market cap of 192.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while RXST trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas RXST's P/E ratio is -4.12. In terms of profitability, MGRM's ROE is -0.85%, compared to RXST's ROE of -0.17%. Regarding short-term risk, MGRM is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
MGRM vs BSGM Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas BSGM's P/E ratio is -5.81. In terms of profitability, MGRM's ROE is -0.85%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, MGRM is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check BSGM's competition here
Neuronetics, Inc. (NASDAQ: STIM)
MGRM vs STIM Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, STIM has a market cap of 190.7M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while STIM trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas STIM's P/E ratio is -6.23. In terms of profitability, MGRM's ROE is -0.85%, compared to STIM's ROE of -1.51%. Regarding short-term risk, MGRM is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check STIM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
MGRM vs MDGS Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas MDGS's P/E ratio is -0.27. In terms of profitability, MGRM's ROE is -0.85%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, MGRM is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
MGRM vs FOCL Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, FOCL has a market cap of 176.5M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while FOCL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas FOCL's P/E ratio is -4.55. In terms of profitability, MGRM's ROE is -0.85%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, MGRM is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
MGRM vs QSI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, QSI has a market cap of 165M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while QSI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas QSI's P/E ratio is -1.81. In terms of profitability, MGRM's ROE is -0.85%, compared to QSI's ROE of -0.47%. Regarding short-term risk, MGRM is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check QSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
MGRM vs QIPT Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas QIPT's P/E ratio is -15.87. In terms of profitability, MGRM's ROE is -0.85%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, MGRM is similarly volatile compared to QIPT. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
MGRM vs LUCD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, LUCD has a market cap of 157.6M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while LUCD trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas LUCD's P/E ratio is -2.23. In terms of profitability, MGRM's ROE is -0.85%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, MGRM is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check LUCD's competition here
Quanterix Corporation (NASDAQ: QTRX)
MGRM vs QTRX Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, QTRX has a market cap of 154M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while QTRX trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas QTRX's P/E ratio is -1.29. In terms of profitability, MGRM's ROE is -0.85%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, MGRM is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
MGRM vs INGN Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, INGN has a market cap of 145.1M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while INGN trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas INGN's P/E ratio is -5.89. In terms of profitability, MGRM's ROE is -0.85%, compared to INGN's ROE of -0.13%. Regarding short-term risk, MGRM is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
MGRM vs ICAD Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ICAD's P/E ratio is -20.37. In terms of profitability, MGRM's ROE is -0.85%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, MGRM is similarly volatile compared to ICAD. This indicates similar risk in terms of short-term price fluctuations for MGRM.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
MGRM vs ECOR Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ECOR has a market cap of 100.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ECOR trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ECOR's P/E ratio is -6.62. In terms of profitability, MGRM's ROE is -0.85%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, MGRM is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
MGRM vs HJLI Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, MGRM's ROE is -0.85%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, MGRM is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
MGRM vs ASXC Comparison September 2026
Monogram Orthopaedics, Inc. (NASDAQ: MGRM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGRM stands at 243.8M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, MGRM is priced at $6.00 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGRM currently has a P/E ratio of -12.00, whereas ASXC's P/E ratio is -1.12. In terms of profitability, MGRM's ROE is -0.85%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, MGRM is less volatile compared to ASXC. This indicates lower risk in terms of short-term price fluctuations for MGRM.Check ASXC's competition here